Thrombotic complications have been documented in patients with cancer, and associated
with tumor progression. Cancer patients have an increased level of circulating …

Microvesicles (MV) are submicrometric membrane fragments (0.1 to 1 μm), released from
the plasma membrane of activated or apoptotic cells. They are characterized by most of the …

Microparticles (MPs) are cellular vesicles produced by all cells in response to apoptosis or
cellular activation. In this brief review, the evidence that MPs mediate the thrombotic …

Microvesicles comprised of exosomes and microparticles are shed from both normal and
malignant cells upon cell activation or apoptosis. Microvesicles promote clot formation …

Microparticles (MP) are vesicular structures released from cells upon activation, malignant
transformation, stress, or death. MP may be derived from the plasma membrane (shed …

Microvesicles (MVs) are small membrane enclosed structures released into the extracellular
space by virtually all cell types. Their composition varies according to the cell origin and the …

Cancer is a prothrombotic state, with an increased prevalence of arterial and venous
thromboemboli. Microparticles (MPs) are sub-micron-sized vesicles derived from activated …

Normal and malignant cells shed from their surface membranes as well as secrete from the
endosomal membrane compartment circular membrane fragments called microvesicles …

Microvesicles (MVs) are small (0.1–1 µm) membrane vesicles released from activated cells.
The surface of MVs can be highly procoagulant due to the presence of the procoagulant …

Microparticles (MP) are submicron vesicles released from various cells in response to
activation, injury or apoptosis. They contain different structural and functional proteins and …